Bivalirudin: An expensive heparin?

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|86|3|397-399

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.3, 2015-09, pp. : 397-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin versus heparin in patients with acute myocardial infarction: A meta‐analysis of randomized trials

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 3, 2015-09 ,pp. : 378-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 3, 2015-09 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bivalirudin versus unfractionated heparin for residual thrombus burden: A frequency‐domain optical coherence tomography study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 575-582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of systemic bivalirudin with catheter‐directed thrombolysis in a patient with heparin‐induced thrombocytopenia: A case report

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : E17-E20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short‐ and long‐term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/IIIA inhibitors: A meta‐analysis of randomized trials

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 3, 2015-09 ,pp. : 364-375

John Wiley & Sons Inc

Access to resources Recommend Favorite